"A high-dose flu vaccine that is currently used for elderly patients can significantly boost the immune response of patients with rheumatoid arthritis, new data show." Read more...
Death from influenza virus in older people may be primarily caused by a damaging immune response to flu and not by the virus itself, new research suggests. The insight could lead to novel strategies for combating flu in the most vulnerable patients, said the researchers.
"The world’s biggest clinical study on the immune effects of probiotics has found that the L. casei 431 strain could reduce the duration of symptoms from the common cold and flu – though no differences were found in the incidence or severity of illness."
